Sort
39,280 grants matching “leukemia”
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
$2,782,255Carl H. June · University Of Pennsylvania · P01 · FY2023 · CA
Pharmacogenetics of Anticancer Agents Research Group
$2,781,123Mark J Ratain · University Of Chicago · U01 · FY2008 · GM
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,779,530Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Immune Modulation After Allogeneic HCT
$2,779,234Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2019 · CA
SWOG Biospecimen Bank
$2,777,143Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2017 · CA
Hematopoietic Cell Transplantation for Hematologic Malignancies
$2,776,839Stephen J Forma · Beckman Research Institute/City Of Hope · P01 · FY2007 · CA
Center for the Spatiotemporal Modeling of Cell Signaling (STMC)
$2,776,118Janet M Oliver · University Of New Mexico · P50 · FY2011 · GM
Genomics of Acute Myelogenous Leukemia
$2,775,922Timothy J Ley · Washington University · P01 · FY2009 · CA
Aging-related hematopoietic stem cell intrinsic and microenvironmental signals in AML transformation
$2,775,137Stavroula Kousteni · Columbia University Health Sciences · P01 · FY2024 · CA
Episcleral Chemotherapy as Salvage Therapy for Eyes with Retinoblastoma
$2,769,464Ricardo A Carvalho · Targeted Therapy Technologies, Llc · RC3 · FY2010 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,767,364Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Environmental Signaling in Reproduction and Pregnancy
$2,766,820Francesco Demayo · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
Characterizing pediatric genomes through an optimized sequencing approach
$2,765,194Shawn E Levy · Hudson-Alpha Institute For Biotechnology · U24 · FY2017 · HD
ECOG Statistical Office Data Management Grant
$2,764,934Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2004 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,760,232Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2019 · CA
Genomics of Acute Myelogenous Leukemia
$2,759,945Timothy J Ley · Washington University · P01 · FY2008 · CA
Epidemiologic Field Studies
$2,758,119Mitchell H Gail · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
$2,756,111Carl H. June · University Of Pennsylvania · P01 · FY2019 · CA
Center for Big Data in Translational Genomics
$2,753,942David H Haussler · University Of California Santa Cruz · U54 · FY2016 · HG
Center for Big Data in Translational Genomics
$2,753,942David H Haussler · University Of California Santa Cruz · U54 · FY2015 · HG
Genomics of Acute Myelogenous Leukemia
$2,749,891Timothy J Ley · Washington University · P01 · FY2014 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,747,943Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2018 · CA
Aging-related hematopoietic stem cell intrinsic and microenvironmental signals in AML transformation
$2,747,089Stavroula Kousteni · Columbia University Health Sciences · P01 · FY2025 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,745,884Robert S Negrin · Stanford University · P01 · FY2019 · CA
SWOG Biospecimen Bank
$2,742,584Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2016 · CA